Retirees, benefit, owning, top, tier, stocks, generating, steady, eddy, income, thousands, stocks, choose, tough, figuring, companies, best, include, portfolios, With, mind, I, dug, details, dozens, top, stocks, figure, might, best, retirees, settled, three, stocks, Read, find, might, right, portfolio, 
IMAGE, SOURCE, EXXONMOBIL, 
Yes, oil, gas, prices, nose, dived, peak, good, thing, oil, gas, producers, drop, prices, corresponding, tumble, share, prices, may, presenting, opportunity, buy, one, best, energy, companies, world, sale, 
ExxonMobil, NYSE, XOM, energy, Goliath, global, presence, business, bigger, simply, finding, extracting, oil, gas, earth, The, company, also, operates, refining, business, turns, oil, gas, products, like, gasoline, runs, big, chemicals, business, 
The, company, upstream, downstream, exposure, energy, markets, make, immune, falling, oil, gas, prices, offer, insulation, earnings, commodity, pops, drops, gives, big, advantage, small, mid, sized, oil, gas, producers, 
For, example, ExxonMobil, earnings, totaled, 16, 2, billion, 2015, despite, headwinds, 2016, still, earned, 1, 8, billion, 1, 7, billion, Q1, Q2, respectively, 
The, ability, generate, earnings, even, difficult, times, provides, level, consistency, shareholder, friendly, Since, merger, Exxon, Mobil, company, reduced, share, count, 40, past, 10, dividend, payout, increased, average, 10, per, In, fact, despite, ups, downs, market, ExxonMobil, increased, dividend, payment, 34, consecutive, That, enviable, track, record, retirees, ought, ignore, especially, given, earnings, could, grow, significantly, coming, decades, global, energy, demand, climbs, 
IMAGE, SOURCE, MICROSOFT, CORP, 
Microsoft, Corp, NASDAQ, MSFT, best, known, Windows, operating, system, Windows, accounts, increasingly, small, share, company, sales, profit, Instead, company, opportunity, generate, revenue, via, online, software, makes, company, top, stock, retirees, buy, 
The, company, Office, 365, provides, businesses, online, access, popular, productivity, tools, excel, revenue, Azure, company, app, platform, taking, Commercial, Office, 365, sales, 54, Q2, ago, Q2, Azure, revenue, doubled, period, Overall, Microsoft, targeting, 20, billion, commercial, cloud, revenue, 2018, 
Microsoft, top, bottom, lines, already, beginning, enjoy, benefit, company, shift, Global, sales, 22, 6, billion, Q2, 500, million, higher, industry, watcher, forecast, earnings, per, share, quarter, outperformed, Wall, Street, watchers, estimates, 0, 11, Assuming, Microsoft, continues, grow, sales, high, margin, cloud, businesses, profit, continue, impress, 
Microsoft, also, makes, sense, retirees, boasts, one, best, balance, sheets, technology, The, company, sitting, 113, billion, cash, exiting, June, gives, plenty, financial, firepower, deals, could, drive, sales, higher, coming, Microsoft, proved, point, earlier, summer, 26, 2, billion, acquisition, LinkedIn, NYSE, LNKD, DL, largest, business, oriented, online, networking, website, LinkedIn, add, nearly, 4, billion, annualized, sales, Microsoft, immediately, Microsoft, expects, LinkedIn, begin, contributing, bottom, line, performance, beginning, fiscal, 2019, 
If, company, reincarnation, financial, firepower, convincing, enough, reasons, buy, might, also, want, remember, Microsoft, consistent, dividend, payer, Currently, shares, yielding, market, beating, 2, 5, 
IMAGE, SOURCE, PFIZER, INC, 
After, enduring, sliding, sales, following, expiration, patents, protecting, 13, billion, per, cholesterol, drug, Lipitor, Pfizer, Inc, NYSE, PFE, growing, 
A, restructuring, CEO, Ian, Reed, made, Pfizer, leaner, recent, acquisitions, commitment, cancer, research, establishing, company, top, player, cancer, treatment, 
The, company, oncology, sales, grew, 54, past, 1, 1, billion, last, quarter, sales, indication, could, heading, much, higher, Sales, Ibrance, breast, cancer, drug, surging, Second, quarter, Ibrance, sales, 514, million, 140, million, quarter, ago, The, company, also, saw, quarterly, sales, Xalkori, lung, cancer, drug, grow, 15, 137, million, period, 
In, addition, sales, growth, drugs, company, significantly, expanded, cancer, footprint, last, week, announced, acquisition, Medivation, NASDAQ, MDVN, Medivation, company, behind, Xtandi, commonly, used, prostate, cancer, drug, industry, watchers, targeting, Xtandi, sales, 2, 8, billion, Since, Xtandi, studied, use, earlier, prostate, cancer, treatment, also, studied, breast, cancer, patients, peak, sales, potential, could, much, higher, current, sales, pace, In, addition, adding, Xtandi, lineup, acquisition, also, nets, Pfizer, two, cancer, drugs, Medivation, pipeline, could, eventually, add, hundreds, millions, dollars, sales, 
Pfizer, targeting, 51, billion, sales, 49, billion, sales, last, expects, deliver, earnings, per, share, 2, 38, 2, 20, last, If, Pfizer, meet, exceed, targets, mark, first, full, top, line, sales, growth, since, 2012, 
PFE, REVENUE, ANNUAL, DATA, BY, YCHARTS, 
Because, Pfizer, sales, profit, ticking, acquisitions, offer, additional, profit, opportunity, could, worth, tucking, stock, retirement, portfolios, The, company, increased, dividend, payout, 50, since, 2012, improving, finances, provide, even, greater, increases, future, 
Before, consider, Medivation, Inc, want, hear, 
Investing, legends, Motley, Fool, Co, founders, David, Tom, Gardner, revealed, believe, 10, best, stocks, investors, buy, right, Medivation, Inc, one, 
